好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Fostering Resilience: The Role of Team Dynamics in Mitigating Burnout and Enhancing Well-being in the Neurocritical Care Unit
Neuro Trauma and Critical Care
P7 - Poster Session 7 (8:00 AM-9:00 AM)
18-010

Staff in neurocritical care unit (NCCU) are particularly vulnerable to burnout, negatively affecting team dynamics and patient care,  after the COVID-19 pandemic. We evaluated the impact of several stakeholder-led resilience-building interventions on staff burnout, team dynamics and trainee educational outcomes in the NCCU.
Burnout in neurocritical care units (NCCU) is an important and under-reported issue, marked by emotional exhaustion, depersonalization, and reduced professional accomplishment. The COVID-19 pandemic exacerbated these challenges, straining healthcare resources, and increasing stress levels. 

Our study design was a participatory, stakeholder-led quality improvement intervention-based study with serial cross-sectional surveys. A multidisciplinary working group identified key drivers of burnout and impaired team dynamics and implemented interventions targeting individual and organizational resilience between December 2023 and September 2024. Strategies included a shared vision statement, zero-tolerance pledge for unprofessional behavior, enhanced leadership communication, recognition mechanisms, team-building professional development sessions and social events, workflow revisions, and restructuring of educational programs.
Surveys were conducted pre-intervention (T0), 6 (T6) and 12 months (T12) post-intervention using the Maslach Burnout Inventory and Team Dynamics (derived from Wellbeing Index) surveys. The average survey response rate was 65% 53% nurses, 20% faculty, 9% fellows, 18% APPs/pharmacists/ancillary staff) . Between T0 and T12, high emotional exhaustion decreased by 43%, depersonalization by 27%, and personal accomplishment increased by 25% (all p<0.05). Team trust/collaboration, workplace wellbeing prioritization, and personal contribution to team dynamics/wellbeing also improved significantly (all p<0.001). Mean in-service exam scores for fellows increased significantly between 2024 and 2025 (+14%, p<0.001), post-intervention.

A participatory, stakeholder-driven quality improvement initiative with multi-pronged interventions targeting resilience and team dynamics reduced burnout, improved team well-being, and enhanced education in high-acuity NCCUs. This framework is feasible, sustainable, and adaptable to other ICU environments. 
Authors/Disclosures
Vishank A. Shah, MD (Johns Hopkins University)
PRESENTER 		Dr. Shah has nothing to disclose.
Junaid Ansari, MD (LSU Health Shreveport) Dr. Ansari has nothing to disclose.
Miriam Quinlan, MD, MPH Dr. Quinlan has nothing to disclose.
Karissa Dushel, RN Miss Dushel has nothing to disclose.
Elizabeth K. Zink, PhD, RN Dr. Zink has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Waranch-Brown.
Jessica P. Jenkins, RN Mrs. Jenkins has nothing to disclose.
Shirley Anderson (Johns Hopkins University School of Medicine) No disclosure on file
Sung-Min Cho, DO (Johns Hopkins Hospital) Dr. Cho has nothing to disclose.
Susanne Muehlschlegel, MD, MPH, FAAN (Johns Hopkins School of Medicine) Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grace Pharmaceuticals Inc.. Dr. Muehlschlegel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Pharmaceuticals Inc.. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from NIH. The institution of an immediate family member of Dr. Muehlschlegel has received research support from NIH. The institution of Dr. Muehlschlegel has received research support from Johns Hopkins Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (StAAR) Award. The institution of Dr. Muehlschlegel has received research support from Trustees of The Patrick and Catherine Weldon Donaghue Medical Research Foundation. The institution of Dr. Muehlschlegel has received research support from Harkin Family Fund (Johns Hopkins Dept. of Neurology). Dr. Muehlschlegel has received personal compensation in the range of $500-$4,999 for serving as a Speaker and Author with 好色先生. Dr. Muehlschlegel has a non-compensated relationship as a Member of Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Muehlschlegel has a non-compensated relationship as a Officer of the Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities.
salia farrokh, PharmD Dr. farrokh has nothing to disclose.
David Hering, NP Mr. Hering has nothing to disclose.
Shawn Trautman (Johns Hopkins University School of Medicine) No disclosure on file
Rachel Bartock, RN Mrs. Bartock has nothing to disclose.
jessica bienstock, MD Dr. bienstock has nothing to disclose.
Jose I. Suarez, MD, FAAN (Johns Hopkins Hospital) Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.